SCHEDULE: Kevin Kotler Discloses 5.9% Stake in AngioDynamics

Kevin Kotler has reported a 5.9% beneficial ownership stake in AngioDynamics, Inc., holding 2,421,526 shares of common stock.

Summary

• Kevin Kotler, a U.S. citizen, has disclosed beneficial ownership of 2,421,526 shares of AngioDynamics, Inc. common stock.
• This ownership represents 5.9% of the total class of securities.
• Kotler holds sole voting power and sole dispositive power over all 2,421,526 shares.
• Of the reported securities, 313,495 shares are owned by Kevin Kotler in his individual capacity.
• The remaining shares are directly owned by accounts managed by Kevin Kotler, with no single managed account beneficially owning more than 5% of the common stock.
• The securities were not acquired or held for the purpose of changing or influencing control of AngioDynamics, Inc., other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, as a significant stake by a known investor can be interpreted as a vote of confidence, even if passive. However, it provides no direct operational or financial insights into the company.

Positives

• A significant individual investor, Kevin Kotler, has taken a substantial 5.9% stake in AngioDynamics, Inc., potentially signaling confidence in the company's long-term prospects.

Negatives

• The filing itself does not contain any negative financial or operational information about AngioDynamics, Inc.

Risks

• The filing does not detail specific operational or financial risks for AngioDynamics, Inc. It is a disclosure of beneficial ownership.

Future Outlook

NA

Management Comments

• Kevin Kotler certified that, to the best of his knowledge and belief, the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of AngioDynamics, Inc., other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

StockSavvy.ai notes that a significant passive stake by an individual investor like Kevin Kotler in a medical device company such as AngioDynamics, Inc. can sometimes precede increased shareholder engagement or a signal of perceived undervaluation within the healthcare sector, although this filing explicitly disclaims intent to influence control.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by Kevin Kotler could influence investor perception and potentially the stock price, signaling a notable investor's interest in AngioDynamics, Inc.

Key Dates

Keywords

AngioDynamics, Kevin Kotler, Beneficial Ownership, Schedule 13G, Common Stock, Medical Devices, Healthcare, Investment, Shareholder